Key result
A single bolus of remifentanil significantly attenuated QTc interval prolongation 1 minute after laryngeal mask airway insertion compared to placebo (442.7 vs. 467.8 ms, p<0.001).
Why the study?
Does a single bolus of remifentanil attenuate QTc prolongation during sevoflurane induction and LMA insertion in healthy women?
RCT (n=40)
Double-blind
Computer-generated sequence of numbers
No
Does a single bolus of remifentanil attenuate QTc prolongation during sevoflurane induction and LMA insertion in healthy women?
A single low-dose bolus of remifentanil effectively attenuates transient QTc prolongation and hemodynamic stimulation associated with laryngeal mask airway insertion during sevoflurane induction.
Supports remifentanil bolus to blunt QTc prolongation at LMA insertion; confirms benefit during sevoflurane induction in women.
PURPOSE: Opioids may affect changes in the corrected QT interval (QTc) during anesthetic induction. This study examine whether a single bolus of remifentanil would prolong QTc after laryngeal mask airway (LMA) insertion during sevoflurane induction. MATERIALS AND METHODS: Forty women of American Society of Anesthesiologists physical status 1 (ASA PS1) undergoing gynecological surgery were studied. All patients were induced using three vital capacity inhalation inductions with 5% sevoflurane. Two minutes after induction, the inspiratory concentration of sevoflurane was reduced to 2%. Using double-blinded randomization, patients were allocated into one of two groups, receiving either saline (placebo group, n = 20) or 0.25 μg.kg⁻¹ remifentanil (remifentanil group, n = 20) over a period of thirty seconds. Sixty seconds later, LMA insertion was performed. Recordings were taken with a 12-lead electrocardiogram at baseline, 2 min after induction and 1 and 3 min after LMA insertion. QTc was calculated by Bazett's formula. The mean arterial pressure (MAP) and heart rate (HR) were also measured at each time point. RESULTS: The QTc interval was significantly prolonged in the placebo group as compared to the remifentanil group at 1 min after LMA insertion (467.8 ± 16.5 vs. 442.7 ± 21.3 ms, p < 0.001). However, there was no significant difference in QTc at 3 min after LMA insertion between the two groups. MAP and HR were significantly higher in the placebo group (p < 0.001). CONCLUSION: A single bolus of remifentanil is safe method to attenuate prolonged QTc associated with insertion of LMA.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2011) conducted an RCT in Healthy patients undergoing gynecological surgery (n=40). Remifentanil vs. Saline placebo was evaluated on Corrected QT interval (QTc) at 1 minute after laryngeal mask airway (LMA) insertion (p=<0.001). A single bolus of remifentanil significantly attenuated QTc interval prolongation 1 minute after laryngeal mask airway insertion compared to placebo (442.7 vs. 467.8 ms, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Yonsei Medical Journal